NCT00230906

Completed

Uremic Toxin Removal With a New High Flux Cellulose Triaceta...

University Hospital, Ghent Source

Compare

Other study identifiers

Sponsor study identifier

2001/182

Study Type

interventional

Reported enrollment (type unavailable)

12

Locations

1 country

Sites

1

Timeline

Study Start

January 2001

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

Not reported

Date not reported

Study Completion

April 2002

Actual (reported)

Brief Summary

Comparison of the uremic toxin removal by haemodialysis either with a low flux or a new high flux cellulose triacetate membrane

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Reported enrollment (type unavailable): 12 participants
Study completion date: April 2002
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Some registry-reported names shown below are not yet linked in this graph.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
January 2001
Date type not reported
This date has not been verified as actual or estimated.
Study Completion
April 2002
Actual (reported)
First Submitted
September 29, 2005
Actual (reported)
First Posted
October 3, 2005
Actual (reported)

Last Updated: December 28, 2007
Status Verified: December 2007
Last Update Submitted: December 19, 2007

Conditions

Haemodialysis

Outcome Measures

Primary Outcomes (1)

Concentration of uremic components after 3 weeks of haemodialysis

Interventions

Haemodialysis with either low or high flux membranesProcedure

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

Chronic haemodialysis patient
Serum albumin \> 3.6 g/dl

You may not qualify if:

Sponsors & Collaborators

Nissho Nipro Europe
Type not reportedcollaborator
University Hospital, Ghent
Otherlead

Study Sites (1)

University Hospital Ghent

Ghent, 9000, Belgium

MeSH Terms

Interventions

Dialysis

Intervention Hierarchy (Ancestors)

Chemistry Techniques, AnalyticalInvestigative TechniquesChemical Phenomena

Study Officials

Raymond Van Holder, MD, PhD
University Hospital, Ghent
PRINCIPAL INVESTIGATOR

Study Design

Study Type: interventional
Phase: not applicable
Allocation: RANDOMIZED
Masking: NONE
Purpose: TREATMENT
Intervention Model: CROSSOVER
Sponsor Type: OTHER

Study Record Dates

First Submitted

September 29, 2005

First Posted

October 3, 2005

Study Start

January 2001

Date type not reported

This date has not been verified as actual or estimated.

Study Completion

April 2002

Actual (reported)

NCT07377500

Dialysate Cooling for the Preservation of Cognitive Function in People Receiving Haemodialysis

Not ApplicableNot Yet Recruiting

NCT01382888

Efficacy and Local Tolerability of Topically Applied Heparin on the Suitability of Newly Constructed Primary Arteriovenous Fistulas in Patients Planned for Haemodialysis

Phase 2Terminated

NCT05729997

Live Classical Music and the Response to the Disease and Its Evolution in Patients With Chronic Renal Failure

Not ApplicableCompleted

NCT00718289

Citrate- Versus Acetate-Based Dialysate in Bicarbonate Haemodialysis: Consequences on Haemodynamics, Coagulation, Acid-Base Status and Electrolytes

Phase 4Completed

NCT02902848

Evaluation of the Validity of the Prothrombin Time Internation Normalised Ratio (PT/INR) Measured at the point-of Care on the Arterial Bloodline of Haemodialysis Extracorporeal Blood Flow

Unknown

NCT00829153

U Clip Study - Study to Compare U Clip Anastomosis With Conventional Continuous Prolene Anastomosis

Phase 1/2Unknown

\< 18 years

Contact the study team to confirm eligibility.

Last Updated

December 28, 2007

Record last verified: 2007-12

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT00230906
Data provider: ClinicalTrials.gov
Source updated: 2007-12-28
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:21:28 UTC

Locations

BE(1)

Uremic Toxin Removal With a New High Flux Cellulose Triacetate Membrane

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

Study Completion

First Submitted

First Posted

Conditions

Outcome Measures

Primary Outcomes (1)

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

Related Links

MeSH Terms

Interventions

Intervention Hierarchy (Ancestors)

Study Officials

Study Design

Study Record Dates

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Study Completion

First Submitted

First Posted

Conditions

Outcome Measures

Primary Outcomes (1)

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

Related Links

MeSH Terms

Interventions

Intervention Hierarchy (Ancestors)

Study Officials

Study Design

Study Record Dates

Source record

Locations